加味生肝湯이 고지방식이로 유발된 지방간에 미치는 영향
Effects of Gamisaenggan-tang on High Fat Diet-induced Nonalcoholic Fatty Liver Disease
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Objectives : The aim of this study was to investigate the effects of Gamisaenggan-tang on high fat diet induced nonalcoholic fatty liver disease. Methods : Rats were randomly divided into four groups. The Normal group was fed a solid diet containing 10% fat. The Gamisaenggan-tang (GS) group was fed a solid diet containing 10% fat and Gamisaenggan-tang (90mg/100g body weight). The Control group was fed a solid diet containing 60% fat. The HFD-Gamisaenggan-tang (HFD-GS) group was fed a solid diet containing 60% fat and Gamisaenggan-tang (90mg/100g body weight). Six weeks later, rats' body weight, liver weight, serum ALT, GGT, ALP levels were measured. Histological findings (Oil red O staining), hepatic triglyceride, TNF-α, and TGF-β levels in the liver tissue were studied. Results : Average body weight of the HFD-GS group was significantly less than that of the Control group. There were no significant liver weight differences among each group. The GGT levels of the HFD-GS group were significantly less than those of the Control group. However, there were no significant differences in the ALT or ALP levels among the groups. TNF-a protein production assessed by western blot analysis was reduced by Gamisaenggan-tang. Greater fat accumulation was observed in the liver tissue of the Control group than in the HFD-GS group, which means the Gamisaenggan-tang has an inhibitory effect on the accumulation of fat in the liver. Conclusion : The results suggest that Gamisaenggan-tang can be potential candidate for the treatment of nonalcoholic fatty liver disease in clinics.
Abstract
Objectives : The aim of this study was to investigate the effects of Gamisaenggan-tang on high fat diet induced nonalcoholic fatty liver disease. Methods : Rats were randomly divided into four groups. The Normal group was fed a solid diet containing 10% fat. The Gamisaenggan-tang (GS) group was fed a solid diet containing 10% fat and Gamisaenggan-tang (90mg/100g body weight). The Control group was fed a solid diet containing 60% fat. The HFD-Gamisaenggan-tang (HFD-GS) group was fed a solid diet containing 60% fat and Gamisaenggan-tang (90mg/100g body weight). Six weeks later, rats' body weight, liver weight, serum ALT, GGT, ALP levels were measured. Histological findings (Oil red O staining), hepatic triglyceride, TNF-α, and TGF-β levels in the liver tissue were studied. Results : Average body weight of the HFD-GS group was significantly less than that of the Control group. There were no significant liver weight differences among each group. The GGT levels of the HFD-GS group were significantly less than those of the Control group. However, there were no significant differences in the ALT or ALP levels among the groups. TNF-a protein production assessed by western blot analysis was reduced by Gamisaenggan-tang. Greater fat accumulation was observed in the liver tissue of the Control group than in the HFD-GS group, which means the Gamisaenggan-tang has an inhibitory effect on the accumulation of fat in the liver. Conclusion : The results suggest that Gamisaenggan-tang can be potential candidate for the treatment of nonalcoholic fatty liver disease in clinics.
참고문헌 (30)
- Yan E, "Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management", Nutr Rev, 65(8), pp.376~384 (2007)
- Ludwig J, "Nonalcoholic steatohepatitis : Mayo Clinic experiences with a hitherto unnamed disease", Mayo Clin Proc, 55(7), pp.434~438 (1980)
- 정재연, "비알코올성 지방간질환의 치료", 대한내과학회지, 13(2s), pp.9~16 (2007)
- Bedogni G, "Prevalence of and risk factors for nonalcoholic fatty liver disease : the Dionysos nutrition and liver study", Hepatolgy, 42(1), pp.44~52 (2005)
- Gambarin-Gelwan M, "Prevalence of nonalcoholic fatty liver disease in woman with polycystic ovary syndrome", Clin Gastroenterol Hepatol, 5(4), pp.496~501 (2007)
- Damaso AR, "Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents", Dig Liver Dis, 40(2), pp.132~139 (2008)
- SanYal AJ, "Nonalcoholic steatohepatitis : Association of insulin resistance and mitochodrial abnormalities", Gastroenterolgy, 120(5), pp.1183~1192 (2001)
- 김홍규, "비알콜성 지방간과 대사성 질환들과의 연관성", 대한내분비학회지, 17(4), pp.526~534 (2002), 대한내분비학회
- 유권, "비알콜성 지방간염", 대한간학회지, 8(1s), pp.66~72 (2002)
- 김선미, "당뇨가 없고 정상체중을 가진 사람에서 비알코올성 지방간 질환과 대사성 증후군", 대한비만학회지, 15(1), pp.44~51 (2006)
- Charles S Lieber, "Model of nonalcoholic steatohepatits", 79(3), pp.502~509 (2004)
- 박상훈, "비알코올성 지방간염의 발병기전과 치료", 대한간학회지, 14(1), pp.12~27 (2008)
- 박원환, "마취유무에 따른 章門・期門穴의 울금약침이 고지방성 식이로 인한 고지혈증 白鼠에 미치는 영향", 대한동의병리학회지, 13(1), pp.92~103 (1999)
- 반상석, "고지방 식이로 유도된 비만 흰쥐에 茵蔯, 枳實, 山？가 미치는 영향", 대한본초학회지, 21(3), pp.55~67 (2006), 대한본초학회
- 김형철, "丹蔘이 고지혈증 흰쥐의 혈중 지질 변화에 미치는 영향", 대한본초학회지, 22(4), pp.239~245 (2007), 대한본초학회
- 吴其恺, "脂炎消煎剂治療非酒精性脂肪肝 63例的臨床觀察", CJ GMTCM, 22(2), pp.34~35 (2007)
- 赵和平, "降脂益肝冲剂治療非酒精性脂肪肝炎的實驗硏究", Drug evaluation, 4(2), pp.114~116 (2007)
- 지형준, "대한약전 및 대한약전외 한약규격주해", pp.109~619 (1998), 한국메디칼인덱스사
- Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346(16), pp.1221~1231 (2002)
- 박중원, "지방간의 진단과 치료", 대한간학회지, 7(1s), pp.64~70 (2001)
- 전국한의과대학 간계내과학 교수 공저, "간계내과학", pp.315~322 (2001), 동양의학연구원
- 류광렬, "만성 B형간염환자에서 자발성 급성 학화 2례", 대한한방내과학회 추계학술대회, pp.73~81 (2004)
- 이창규, "生肝湯이 CCl₄및 d-galactosamine에 의하여 유발된 흰쥐의 간장해에 미치는 영향", pp.1986
- 최서형, "生肝湯과 그 분획이 간장보호, 혈소판응집능 및 일반 면역기능에 미치는 영향", pp.1987
- 류경하, "生肝湯이 고지혈증에 미치는 영향", pp.1988
- 승현석, "加減生肝湯을 투여하여 호전된 급성 간염 2례", 대한한방내과학회, 23(2), pp.226~237 (2002)
- 김영철, "중풍을 동반한 초기간경변증 치험 1례", 대한한방내과학회 별책부록, 19(2), pp.21~28 (1999)
- 김동우, "加減生肝湯을 투여한 간암환자에 관한 연구", 대한한의학회지, 12(2), pp.233~249 (1991)
- Baumgardner JN, "A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet", Am J Physiol Gastrointest Liver Physiol, 294(1), pp.G27~G38 (2008)
- Xue Zhi Hong, "Effect of fenofibrate and xuezhikang on high-fat diet-induced nonalcoholic fatty liver disease", Clinical and experimental pharmacology and physiology, 34, pp.27~35 (2007)